IREN to Release Third Quarter Results and Host Conference Call on May 15, 2024
SYDNEY, Australia, May 06, 2024 (GLOBE NEWSWIRE) — IREN (Iris Energy Limited) (NASDAQ: IREN) (together with its subsidiaries, “IREN” or […]
April 2024 Monthly Investor Update
SYDNEY, Australia, May 06, 2024 (GLOBE NEWSWIRE) — IREN (NASDAQ: IREN) (together with its subsidiaries, “IREN” or “the Company”), a […]
Fortrea Reschedules Release of First Quarter 2024 Financial Results and Conference Call
DURHAM, N.C., May 06, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), […]
Bitcoin Depot Schedules First Quarter 2024 Conference Call for Tuesday, May 14th at 10:00 am ET
ATLANTA, May 06, 2024 (GLOBE NEWSWIRE) — Bitcoin Depot (“Bitcoin Depot” or the “Company”), a U.S.-based Bitcoin ATM operator and […]
Hour Loop Reports First Quarter 2024 Results
Returns to Profitability Despite Warning Signs for the Overall Economy Provides Full Year 2024 Revenue and Net Income Guidance Redmond, […]
Kforce Inc. Announces Transfer of Listing of Common Stock to the New York Stock Exchange
TAMPA, Fla., May 06, 2024 (GLOBE NEWSWIRE) — Kforce Inc. (Nasdaq: KFRC) (“Kforce”), a solutions firm that specializes in technology […]
Quipt Home Medical Corp. to Announce Fiscal Second Quarter 2024 Financial Results on May 15, 2024
CINCINNATI, May 06, 2024 (GLOBE NEWSWIRE) — Quipt Home Medical Corp. (the “Company”) (NASDAQ: QIPT) (TSX: QIPT), a U.S. based […]
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass., May 06, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (NASDAQ:OCUL, “Ocular”, the “Company”), a biopharmaceutical company committed to […]
Dime Announces Expansion in Williamsburg With Deposit-Focused Group
HAUPPAUGE, N.Y., May 06, 2024 (GLOBE NEWSWIRE) — Dime Community Bancshares, Inc. (NASDAQ: DCOM) (the “Company” or “Dime”), the parent […]
Plus Therapeutics Announces Private Placement Financing of up to $18 Million
AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted […]
